23andMe’s research portal allows qualified scientists outside of the 23andMe community to access the data and research while protecting the privacy of 23andMe’s customers.
The agreement includes collaboration between the two companies on certain genome-wide association studies and clinical trial recruitment. One such study will focus on better understanding the genetics of lupus.
More articles on genomics:
IBM Watson-powered app to deliver personalized health info
IBM, Cleveland Clinic to use Watson for cancer genomics pilot
Phoenix Children’s Hospital opens pediatric genomic research & precision medicine institute
